More and more people are microdosing Ozempic, a popular weight loss drug, due to high costs and uncomfortable side effects.

Semaglutide and tirzepatide confer greater improvements in life expectancy than naltrexone/bupropion and ...

Popular anti-diabetes and obesity drug Mounjaro, containing the active ingredient tirzepatide, is now available in India in a ...

The versions affected are called compounded medications, which have the same active ingredients as the name brands. The ...

A new study found that fair prices for medications like Wegovy and Zepbound would be hundreds less per month than they are ...

Compounding pharmacies have been allowed to essentially make a cheaper version of Eli Lilly's Zepbound, but they have to stop ...

Eli Lilly has launched new single-dose 2.5mg and 5.0mg vials of its obesity drug Zepbound in a move that it said would make it easier for people paying for the drug out-of-pocket to afford treatment.

Eli Lilly's drive to provide as many treatment options as possible for its weight-loss drug Zepbound has continued with the launch of new high-dose vials sold at a $150 discount to its auto ...

With two billion people overweight or obese and the obesity treatment market expected to reach $200 billion by 2031, Olio Labs has released a groundbreaking study. The data uncover fundamental ...

Discuss the dose schedule with your health care professional. Remember that this medication has been prescribed because your health care professional has judged that the benefit to you is greater ...